Article Text

Download PDFPDF
P111 Insulin-like Growth Factor 1 and risk of depression in older people
  1. S Chigogora1,
  2. P Zaninotto1,
  3. M Kivimaki1,
  4. A Steptoe1,
  5. GD Batty1,2
  1. 1Epidemiology and Public Health, University College London, London, UK
  2. 2Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh, UK


Background Depressive disorders are a leading cause of disability in older age. While the role of psychosocial and behavioural predictors has been well-examined, little is known about the biological origins of depression. Findings from animal studies suggest a link between Insulin-like Growth Factor 1 (IGF-1) and depression. Mice whose Insulin-like Growth Factor 1 (IGF-1) was knocked out using viral vectors displayed increased symptoms of depression, while IGF-1 infusions had an antidepressant effects on depressed mice. Human studies of this association have so far yielded conflicting results.

In the present study, we examined the association of IGF-1 with both self-reported depression symptoms and physician diagnosis of depression.

Methods In 6,017 adults (mean age of 65.7 (SD = 9.3); range 50–99) from the English Longitudinal Study of Ageing, serum levels of IGF-1 were measured during a nurse visit in 2008 (mean 15.9, SD = 5.7). Depression symptoms were assessed in 2008 and 2012 using the eight item Centre for Epidemiological Studies Depression Scale (CES-D) (mean 1.2, SD = 1.8). Multivariable logistic regression analyses were used to test associations.

Results The main finding of this study of was that having IGF-1 levels in the lowest and highest quintiles was associated with a slightly higher risk of depression symptoms in older people. With the lowest risk apparent at median levels of IGF-1, a ‘U’-shaped relationship was therefore observed in some analyses. In men, using the lowest quintile of IGF-1 as the referent, the age-adjusted odds ratios (95% confidence interval) of developing depression symptoms after four years of follow-up, for increasing quintiles of IGF-1, were: 0.51 (0.28–0.91), 0.50 (0.27–0.92), 0.63 (0.35–1.15) and 0.63 (0.35–1.13) (P-value for quadratic effect 0.002). Statistical significance was not achieved for all levels of IGF-1. Similar results were observed for women, and for the relationship between IGF-1 and physician diagnosed depression. These associations were partially attributable to co-morbidities, psychosocial and behavioural factors, and adverse socioeconomic circumstances.

Conclusion In the present study of older adults, there was some evidence that moderate levels of IGF-1 levels conferred a reduced risk of depression. Paucity of data in this field justifies further investigation.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.